UBS AM’s Generate Biomedicines GENB Stock Holding History
Bought
Maintained
Sold
Other funds holding GENB
UBS AM's GENB Position: Q3 2026 in Review
UBS AM opened a new position in Generate Biomedicines (GENB) in Q3 2026: 174 shares worth $2.61K. The stake represents ﹤0.01% of the portfolio and ranks #4003 among its holdings.
86 funds tracked by Wall St. Rank hold GENB as of Q3 2026.
- UBS AM held 174 shares of Generate Biomedicines worth $2.61K as of Q3 2026.
- Generate Biomedicines was a new UBS AM position in Q3 2026.
- Generate Biomedicines made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4003 holding.
- 86 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.